Oculis to Participate in Upcoming November Investor Conferences
(NasdaqGM:OCS),(Iceland:OCS),(Iceland:OCS.IC), ZUG, Switzerland, Nov. 05, 2025 (GLOBE NEWSWIRE) — Oculis Holding AG (Nasdaq: OCS / XICE: OCS) (“Oculis”), a global biopharmaceutical company focused on breakthrough innovations to address significant unmet medical needs in neuro-ophthalmology and ophthalmology, announced today that Oculis' management will participate in upcoming investor conferences in November. Oculis is pleased to present updates […]